Topic List : Immunology
Schneider on disease and data sculptures
Many infectious diseases, including malaria, are marked by cyclical ups and downs. David Schneider takes a creative approach to making sense of those ups and downs.
'Vaccine’ destroys tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
Screen could reveal immunotherapy targets
Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.
Drug blocks several mosquito-borne viruses
A new Stanford study details how to shut off proteins in mammalian cells to keep viruses such as Zika, dengue and West Nile from replicating in them.
Multiple food allergies treated safely
Combining an antibody drug, omalizumab, with a procedure to desensitize children to multiple food allergies is safe and effective, according to a new study by Stanford researchers.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.
‘Drugs’ from gut bugs
Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.
Possible new cell therapy for leukemia
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
Previously uncharacterized bacteria found in dolphins
Researchers have discovered poorly understood bacterial lineages in the mouths of dolphins.
Center to support cancer immunotherapy
Stanford is one of four institutions to receive National Cancer Institute funding to analyze patients’ immune function and tumor profiles as part of a public-private partnership to accelerate cancer therapies.